Your browser doesn't support javascript.
loading
Ultrasound-guided percutaneous injection to treat de Quervain's disease using three different techniques: a randomized controlled trial.
Orlandi, Davide; Corazza, Angelo; Fabbro, Emanuele; Ferrero, Giulio; Sabino, Giuseppe; Serafini, Giovanni; Silvestri, Enzo; Sconfienza, Luca Maria.
Afiliação
  • Orlandi D; Department of Radiology, Genoa University, Via L.B. Alberti 4, 16100, Genova, Italy, theabo@libero.it.
Eur Radiol ; 25(5): 1512-9, 2015 May.
Article em En | MEDLINE | ID: mdl-25465711
ABSTRACT

PURPOSE:

To compare the six-month outcome of three different ultrasound-guided treatments for de Quervain's disease (DQD).

METHODS:

We prospectively treated 75 consecutive patients (51 females, 24 males, mean age ± standard deviation = 45.3 ± 9.8 years) with DQD. Patients' features (hand dominance, intraretinaculum septum, accessory tendons) were recorded. Visual analogue scale (VAS), reduced disability (quickDASH) score, and retinaculum thickness were evaluated at baseline and after one (excluding retinaculum thickness), three, and six months. Patients were randomized into three groups of 25 patients each treated under ultrasound guidance Group A (1 ml methylprednisolone acetate; mean baseline thickness = 1.6 mm; mean baseline VAS = 6; mean baseline quickDASH = 55); Group B (1 ml methylprednisolone acetate +15-day delayed 2 ml saline 0.9 %; 1.4; 6; 56); Group C (1 ml methylprednisolone acetate +15-day delayed 2 ml low molecular weight hyaluronic acid; 1.7; 6; 55).

RESULTS:

After one month results were Group A mean VAS = 2; mean quickDASH = 23; Group B 2; 22; Group C 2; 21. After three months results were Group A retinaculum thickness = 0.7 mm; 3; 27); Group B 0.8 mm; 1; 25; Group C 0.5 mm; 1; 23. After six months results were Group A 1.5 mm; 3; 51; Group B 1 mm; 2; 51; Group C 0.7 mm; 1; 26 (P < 0.001 for all vs. baseline). Patients' age, sex, hand dominance, presence of subcompartment dividing septum, and supernumerary tendons had no influence on outcome (P ≥ 0.177).

CONCLUSION:

Addition of hyaluronic acid to ultrasound-guided injections of steroids to treat DQD seems to improve the outcome and to reduce the recurrence rate. KEY POINTS • Ultrasound guidance allows for safe injection procedures to treat de Quervains' disease • Steroid injections allow prompt recovery in de Quervain's disease with short-term recurrence • Addition of hyaluronic acid allows recurrence rate reduction compared to simple steroid injections.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Metilprednisolona / Cloreto de Sódio / Ultrassonografia de Intervenção / Doença de De Quervain / Ácido Hialurônico Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Metilprednisolona / Cloreto de Sódio / Ultrassonografia de Intervenção / Doença de De Quervain / Ácido Hialurônico Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article